PA GOODDOCTOR (01833) Reports H1 2025 Revenue of 2.5 Billion Yuan, Net Profit Surges 136.8%

Stock News
08/19

On August 19, 2025, Ping An Healthcare and Technology Company Limited (stock name "PA GOODDOCTOR", 01833, hereinafter referred to as "the Company") announced its interim results for the six months ended June 30, 2025. The data shows that the company maintained steady overall operations with strong growth momentum, achieving dual improvements in revenue and profitability.

During the reporting period, the company recorded total revenue of 2.5 billion yuan, representing a year-on-year increase of 19.5%. Net profit attributable to shareholders reached 134 million yuan, surging 136.8% year-on-year. Notably, revenue from the integrated financial client segment (F-end) and enterprise segment (B-end) corporate health business grew 30.2% year-on-year.

The company has deepened the development of its "medical-insurance synergy" model, continuously strengthening collaboration with Ping An Group's comprehensive financial business. Meanwhile, in the enterprise health management sector, the company has partnered with group members to create a "commercial insurance + health security entrustment + medical and health services" product system, vigorously expanding enterprise clients and achieving steady revenue growth with comprehensive improvement in profitability quality.

During the reporting period, F-end paying users numbered approximately 20 million, up 34.6% year-on-year. The company served over 3,500 paying enterprise clients, with B-end paying users exceeding 3.6 million, representing a 39.2% year-on-year increase.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10